【摘要】 采用 Ｓｅｌｄｉｎｇｅｒｓ穿刺法，导管超选择至肝固有动脉以远，灌注^３２Ｐ－玻璃微球(^３２Ｐ－ＧＭＳ)，对７９例肝细胞肝癌（ＨＣＣ）实施了９９次内照射介入治疗。结果表明，Ａ方案半年及１、２、３年生存率分别为１００％、９６．７％、５６．７％和４３．３％；Ｂ方案分别为９７．９％、９１８％、６１．２％和５１．０％。经治后的中位生存时间为５８５天。多因素分析显示：肝功能、肿瘤大小、临床类型及^３２Ｐ－ＧＭＳ在瘤体内积聚情况是影响生存率的预后因素。说明^３２Ｐ－ＧＭＳ是一种安全、有效的肝癌治疗方法。更多还原

【Abstract】 To evaluate the therapeutic effect of phosphorus-32 glass microsphere (³²P-GMS) on hepatocellular carcinoma. By Seldinger’s procedure, super-selective catheterization was performed to the distal end of proper hepatic artery for instilling ³²p-GMS. Ninety-nine times of interventional internal irradiation were accomplished in 79 cases of hepatocellular carcinoma. Results shows that surviving rates in A or B regimen at half year, 1, 2 and 3 years were 100%, 96.7%, 56.7% and 43.3% or 97.9%, 91.8%, 61.2% and 51.0% respectively. The median surviving time after therapy was 585 days single multifactorial analysis revealed liver function, tumor size, clinical typing and accumulation of ³²P-GMS in the tumor mass and the therapeutic regime were the prognostic factors influencing the surviving rate of the patient. Conclusion:³²P-GMS is a safe, effective and economic method for the therapeutic measure in treating hepatocellular carcinoma.更多还原